194 related articles for article (PubMed ID: 11421142)
1. Childhood acute lymphoblastic leukemia: current perspectives.
Landier W
Oncol Nurs Forum; 2001 Jun; 28(5):823-33; quiz 834-5. PubMed ID: 11421142
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes in survivors of childhood acute lymphoblastic leukemia.
Nathan PC; Wasilewski-Masker K; Janzen LA
Hematol Oncol Clin North Am; 2009 Oct; 23(5):1065-82, vi-vii. PubMed ID: 19825453
[TBL] [Abstract][Full Text] [Related]
4. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
[TBL] [Abstract][Full Text] [Related]
5. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
6. Moyamoya syndrome following childhood acute lymphoblastic leukemia.
Kikuchi A; Maeda M; Hanada R; Okimoto Y; Ishimoto K; Kaneko T; Ikuta K; Tsuchida M;
Pediatr Blood Cancer; 2007 Mar; 48(3):268-72. PubMed ID: 16615044
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
8. High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Salo J; Lanning M; Vilkkumaa I; Harila-Saari AH
Pediatr Blood Cancer; 2010 Aug; 55(2):331-6. PubMed ID: 20582965
[TBL] [Abstract][Full Text] [Related]
9. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM
J Clin Oncol; 2007 Apr; 25(10):1183-9. PubMed ID: 17401007
[TBL] [Abstract][Full Text] [Related]
10. The childhood leukemias.
Colby-Graham MF; Chordas C
J Pediatr Nurs; 2003 Apr; 18(2):87-95. PubMed ID: 12720205
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
[TBL] [Abstract][Full Text] [Related]
12. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
13. The neurodevelopmental sequelae of childhood leukaemia and its treatment.
Temming P; Jenney ME
Arch Dis Child; 2010 Nov; 95(11):936-40. PubMed ID: 20980277
[TBL] [Abstract][Full Text] [Related]
14. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
[TBL] [Abstract][Full Text] [Related]
15. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
16. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
17. Late effects in long-term survivors after treatment for childhood acute leukemia.
Haddy TB; Mosher RB; Reaman GH
Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted treatment of pediatric acute lymphoblastic leukemia.
Jeha S; Pui CH
Hematol Oncol Clin North Am; 2009 Oct; 23(5):973-90, v. PubMed ID: 19825448
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute lymphoblastic leukemia in Hong Kong children: HKALL 93 study.
Li CK; Chik KW; Chan GC; Yuen HL; Lee AC; Li CK; Shing MM; Ha SY; Luk CW; Ling SC; Cheung AY;
Hematol Oncol; 2003 Mar; 21(1):1-9. PubMed ID: 12605417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
